Zevra Therapeutics signals accelerated MIPLYFFA adoption and $148.3M capital infusion while expanding global reach Zevra Therapeutics signals accelerated MIPLYFFA adoption and $148.3M capital infusion while expanding global reach Post ContentzvraRead More You might also be interested in reading United States Cellular declares $23 special dividend. May 14, 2025 In Mainstream ← Previous post Next post →